Mast cells as initiators of immunity and host defense

Experimental Dermatology

Volumn 10, Issue 1, 2001, Pages 1-10

  Henz, B M ^a,b,c   Maurer, M ^a,b,c   Lippert, U ^a,b,c   Worm, M ^a,b,c   Babina, M ^a,b,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Adhesion molecules; Antigen presentation; Cytokines; Innate immunity; Mast cells

Indexed keywords

B7 ANTIGEN; BACTERIAL ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOSIALIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLLEN ANTIGEN;

ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ANTIGEN EXPRESSION; AUTOIMMUNITY; B LYMPHOCYTE; BASOPHIL; CELL INTERACTION; CELLULAR IMMUNITY; HOST RESISTANCE; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; MAST CELL; PHAGOCYTOSIS; REVIEW; T LYMPHOCYTE;

ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELL ADHESION MOLECULES; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNITY; MAST CELLS; PHAGOCYTOSIS; T-LYMPHOCYTES;

EID: 0035143440     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2001.100101.x     Document Type: Review

References (102)

1. Mast cells
2. Mast cells
3. Immunopathology and human mast cell cytokines
4. Mast cells and their mediators in wound healing - Active participants or innocent bystanders?
5. Functional and ultrastructural insights into the immunobiology of mouse and human mast cells
6. The two faces of the mast cell
7. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes
8. Mast cells in the cytokine network - The what, where from and what for
9. Interactions between neurotrophins and mast cells
10. Release of mediators from purified rat mast cells during phagocytosis
11. Evidence that tissue mast cells derive from mononuclear phagocytes
12. In vitro generation of mast cell-like cells from human peripheral mononuclear phagocytes
13. Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation
14. In situ degranulation of human nasal mucosal mast cells: Ultrastructural features and cell-cell association
15. Mast-cell-T-cell interactions
16. Mast cells and urticaria
17. MHC class II expression in different forms of urticaria
18. Upregulation of tumor necrosis factor α and interleukin-3 expression in lesional and uninvolved skin in different types of urticaria
19. Human mast cells produce IL-8
20. Comparative cytokine gene expression, regulation and release by human mast cells
21. Human skin mast cells rapidly release preformed and newly generated TNF-α and IL-8 but not IL-4, IL-5 or IL-13 following stimulation with anti-IgE and other secretagogues
22. Neutrophil activating factor (NAP-1) is also chemotactic for T lymphocytes
23. Lymphotactin gene expression in mast cells following Fcε receptor I aggregation
24. + T lymphocyte chemoattractant factor, IL-16
25. Mast cell activation and migration to lymph nodes during induction of an immune response in mice
26. Regulation of T lymphocyte trafficking into lymph nodes during induction of an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta
27. Interactions of immature human mast cells with extracellular matrix: Expression of specific integrin receptors and their role in cell adhesion to extracellular proteins
28. Adhesion molecules on the human mast cell line HMC-1 are upregulated during cell activation
29. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells
30. In vitro and in vivo immunostimulatory potential of bone marrow-derived mast cells on B- and T-lymphocyte activation
31. Absence of MHC class II antigen on mast cells at sites of inflammation in human skin
32. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma
33. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells
34. Interferon-γ-like molecule induces Ia antigens on cultured mast cell progenitors
35. Are the mast cells antigen presenting cells?
36. IFN-γ-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1
37. Induction of MHC class II antigen expression on human mast cells
38. +, and expresses aminopeptidase N (CD13)
39. Rat peritoneal mast cells present antigen to a PPD-specific T cell line
40. Presentation of soluble antigens by mast cells: Upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma
41. + T lymphocytes
42. Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria
43. Internalization of FimH+ Escherichia coli by the human mast cell line (HMC-1 5C6) involves protein kinase C
44. + T cell hybridomas by human mast cells through superantigen presentation
45. Interleukin 4 promotes expression of mast cell ICAM-1 antigen
46. The human cardiac mast cell: Localization, isolation, phenotype, and functional characterization
47. Monoclonal antibodies to leucosialin (CD43) induce homotypic aggregation of the human mast cell line HMC-1: Characterization of leucosialin on HMC-1 cells
48. Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies
49. Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules
50. Human conjunctival mast cells: Expression of Fc epsilonRI, c-kit, ICAM-1, and IgE
51. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4
52. Modulation of intercellular adhesion molecule 1 (ICAM-1) expression on the human mast-cell line (HMC)-1 by inflammatory mediators
53. 2-integrins and ICAM-1 on human leukemic (HMC-1) mast cells
54. CD43 (leukosialin, sialophorin) expression is differentially regulated by retinoic acids
55. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes
56. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes
57. Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells
58. ICAM-3 (CD50) is expressed by human mast cells: Induction of homotypic mast cell aggregation via ICAM-3
59. 3 receptor
60. on HMC-1 cells
61. CD43, a molecule with multiple functions
62. Leukosialin (CD43) is proteolytically cleaved from stimulated HMC-1 cells
63. Further characterization of surface membrane structures expressed on human basophils and mast cells
64. Human native soluble CD40L is a biologically active trimer, processed inside microsomes
65. Molekulargenetische grundlagen der allergie: Ansätze für eine rationale therapie
66. Induction of human IgE synthesis in B cells by mast cells and basophils
67. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells
68. Upregulation of CD40-CD40 ligand expression in IgE associated cutaneous diseases
69. Cultured basophils but not cultured mast cells induce human IgE synthesis in B cells after immunologic stimulation
70. Comparative cytokine gene expression, regulation and release by human mast cells
71. Human lung mast cells release small amounts of interleukin-4 and tumour necrosis factor-α in response to stimulation by anti-IgE and stem cell factor
72. A link between catalytic activity, IgE-independent mast cell activation and allergenicity of bee venom phospholipase A2
73. Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitisation with antigen-specific IgE
74. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3
75. Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex
76. STAT6-independent production of IL-4 by mast cells
77. Induction and enhancement of FcεRI-dependent mast cell degranulation following coculture with activated T cells: Dependency on ICAM-1 and leukocyte function-associated antigen (LFA)-1 mediated heterotypic aggregation
78. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact
79. Multifunctional cytokine expression by human mast cells: Regulation by T cell membrane contact and glucocorticoids
80. Mouse bone marrow-derived mast cells and mast cell lines constitutively produce B cell growth and differentiation activities
81. IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway
82. Mast cells in psoriatic skin are strongly positive for interferon-gamma
83. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α
84. Critical protective role of mast cells in a model of acute septic peritonitis
85. Impaired mast cell dependent natural immunity in complement C3-deficient mice
86. Mast cells as sentinels of innate immunity
87. Mast cells in innate immunity
88. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice
89. The mast cell tumore necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48
90. Involvement of cellular caveolae in bacterial entry into mast cells
91. Cutting edge: Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice
92. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells
93. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis
94. Role of interleukin-3 in mast-cell and basophil development and in immunity to parasites
95. Requirement for vasoactive amines for production of delayed type hypersensitivity
96. Two distinct types of cellular mechanisms in the development of delayed hypersensitivity in mice: Requirement of either mast cells or macrophages for elicitation of the response
97. Mast cell derived TNF regulates neutrophil recruitment during contact hypersensitivity reactions (CHSR)
98. 2 cytokines and mast cells play a crucial role in the induction of para-phenylenediamine (PPD) induced contact hypersensitivity in mice
99. Role of mucosal mast cells in early vascular permeability changes of intestinal DTH reaction in the rat
100. Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease
101. An immunohistochemical study on GvHD-like lesion induced in ALY/ALY mice transplanted with B6 bone marrow cells
102. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs-host disease